Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients by de Witte, J H, Sweep, C G J, Klijn, J G M, Grebenschikov, N, Peters, H A, Look, M P, van Tienoven, Th H, Heuvel, J J T M, van Putten, W L J, Benraad, Th J, Foekens, J A

Get full text

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer by Witte, J H de, Sweep, C G J, Klijn, J G M, Grebenschikov, N, Peters, H A, Look, M P, Tienoven, ThH van, Heuvel, J J T M, Vries, J Bolt-De, Benraad, ThJ, Foekens, J A

Get full text

The Prognostic Value of BCAR1 in Patients with Primary Breast Cancer by Dorssers, Lambert C J, Grebenchtchikov, Nicolai, Brinkman, Arend, Look, Maxime P, van Broekhoven, Simone P J, de Jong, Danielle, Peters, Harry A, Portengen, Henk, Meijer-van Gelder, Marion E, Klijn, Jan G M, van Tienoven, Doorlene T H, Geurts-Moespot, Anneke, Span, Paul N, Foekens, John A, Sweep, Fred C G J

Get full text

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours by Witte, J H de, Foekens, J A, Brünner, N, Heuvel, J J T M, Tienoven, ThH van, Look, M P, Klijn, J G M, Geurts-Moespot, A, Grebenchtchikov, N, Benraad, ThJ, Sweep, C G J

Get full text